Venlafaxine-trazodone

From Psychiatrienet
Revision as of 14:59, 7 May 2009 by Alexandra (talk | contribs) (Created page with '{{ Drugswitch | from = venlafaxine | to = trazodone | stop = * Gradually reduce dosage of venlafaxine to a maximum of 75 mg/day, when this dosage is > 75 mg/day. * When a dos...')
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Venlafaxine
Type Antidepressant
Group SNRI
links
Medscape Venlafaxine
PubChem 5656
PubMed Venlafaxine
Kompas (Dutch) Venlafaxine
Wikipedia Venlafaxine
Trazodone
Type Antidepressant
Group other
links
Medscape Trazodone
PubChem 5533
PubMed Trazodone
Kompas (Dutch) Trazodone
Wikipedia Trazodone

Switch medication from venlafaxine to trazodone.[1] [2]

Nietinrijdenbord.png Stop venlafaxine
  • Gradually reduce dosage of venlafaxine to a maximum of 75 mg/day, when this dosage is > 75 mg/day.
  • When a dosage of 75 mg/day is reached, stop administration.
Eenrichtingbord.png Start trazodone
  • Day 1: start administration of trazodone the next day in a dosage of 300 mg/day
  • If necessary, increase dosage of trazodone to a maximum of 400 mg/day.


  1. Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
  2. Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.